Comparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumors

Detalhes bibliográficos
Autor(a) principal: Vilaca, Natalia
Data de Publicação: 2017
Outros Autores: Machado, Ana F., Morais-Santos, Filipa, Amorim, Ricardo, Neto, A. Patricia, Logodin, Enora, Pereira, Manuel F. R., Sardo, Mariana, Rocha, Joao, Parpot, Pier, Fonseca, A. M., Baltazar, Fátima, Neves, Isabel C.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/47909
Resumo: Several silica microporous structures have been studied for their potential as drug delivery systems (DDS) over the last years. However, systematic studies comparing host structures with different topologies and particle sizes, and toxicity studies to human cancer cells, are scarce. In the present work, 3D crystalline structures, three different zeolites (large, medium and small pore size) and one titanosilicate (large pore size) were used as hosts for loading 5-fluorouracil (5-FU), an anticancer drug currently used to treat several malignant tumors. Here, we (i) compared the loading capacity and drug release profiles of the different hosts in simulated body fluid conditions, including host structure stability studies; (ii) established the kinetic parameters for the release of 5-FU and (iii) studied the effect of 5-FU encapsulation in the viability of human breast and colon cancer cells, with determination of the potentiation factor. The loading capacity and the release profile of the DDS were revealed to be dependent on the porous framework of the host structures. Decrease in pH to 2.0 (simulation of gastro-intestinal fluid), showed stability of the host structures, with minimal leaching of Al3+ and no Ti4+ for long periods of time (up to 72 h). All DDS drug release profiles fitted the Weibull model. These silica microporous structures were revealed to be non-toxic to the cancer cells, while all DDS endorsed the important 5-FU potentiation effect on cell viability.
id RCAP_5a8c21fd45f47b20804b8d3e64e32575
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/47909
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Comparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumorsScience & TechnologySeveral silica microporous structures have been studied for their potential as drug delivery systems (DDS) over the last years. However, systematic studies comparing host structures with different topologies and particle sizes, and toxicity studies to human cancer cells, are scarce. In the present work, 3D crystalline structures, three different zeolites (large, medium and small pore size) and one titanosilicate (large pore size) were used as hosts for loading 5-fluorouracil (5-FU), an anticancer drug currently used to treat several malignant tumors. Here, we (i) compared the loading capacity and drug release profiles of the different hosts in simulated body fluid conditions, including host structure stability studies; (ii) established the kinetic parameters for the release of 5-FU and (iii) studied the effect of 5-FU encapsulation in the viability of human breast and colon cancer cells, with determination of the potentiation factor. The loading capacity and the release profile of the DDS were revealed to be dependent on the porous framework of the host structures. Decrease in pH to 2.0 (simulation of gastro-intestinal fluid), showed stability of the host structures, with minimal leaching of Al3+ and no Ti4+ for long periods of time (up to 72 h). All DDS drug release profiles fitted the Weibull model. These silica microporous structures were revealed to be non-toxic to the cancer cells, while all DDS endorsed the important 5-FU potentiation effect on cell viability.N. V., F. M. S. and R. A. are recipients of PhD fellowships (SFRH/BD/97797/2013, SFRH/BD/87139/2012 and SFRH/BD/98002/2013) from Foundation for Science and Technology (FCT, Portugal). MS also acknowledges FCT for a post-doc grant (SFRH/BPD/65978/2009). This work has been developed under the scope of the project NORTE-01-0145-FEDER-000013 and the project BioTecNorte (operation NORTE-01-0145-FEDER-000004), supported by the Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER). This work also has been funded by national funds (FCT), through the projects: Centre of Chemistry (UID/QUI/00686/2013 and UID/QUI/0686/2016); CICECO (PEst-C/CTM/LA0011/2013, F-COMP-01-0124-FEDER-037271); LSRE/LCM (POCI-01-0145-FEDER-006984) and ICVS/3B's (POCI-01-0145-FEDER-007038).info:eu-repo/semantics/publishedVersionRoyal Society of ChemistryUniversidade do MinhoVilaca, NataliaMachado, Ana F.Morais-Santos, FilipaAmorim, RicardoNeto, A. PatriciaLogodin, EnoraPereira, Manuel F. R.Sardo, MarianaRocha, JoaoParpot, PierFonseca, A. M.Baltazar, FátimaNeves, Isabel C.2017-01-012017-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/47909eng2046-206910.1039/c7ra01028ainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:35:47Zoai:repositorium.sdum.uminho.pt:1822/47909Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:31:42.305344Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Comparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumors
title Comparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumors
spellingShingle Comparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumors
Vilaca, Natalia
Science & Technology
title_short Comparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumors
title_full Comparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumors
title_fullStr Comparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumors
title_full_unstemmed Comparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumors
title_sort Comparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumors
author Vilaca, Natalia
author_facet Vilaca, Natalia
Machado, Ana F.
Morais-Santos, Filipa
Amorim, Ricardo
Neto, A. Patricia
Logodin, Enora
Pereira, Manuel F. R.
Sardo, Mariana
Rocha, Joao
Parpot, Pier
Fonseca, A. M.
Baltazar, Fátima
Neves, Isabel C.
author_role author
author2 Machado, Ana F.
Morais-Santos, Filipa
Amorim, Ricardo
Neto, A. Patricia
Logodin, Enora
Pereira, Manuel F. R.
Sardo, Mariana
Rocha, Joao
Parpot, Pier
Fonseca, A. M.
Baltazar, Fátima
Neves, Isabel C.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Vilaca, Natalia
Machado, Ana F.
Morais-Santos, Filipa
Amorim, Ricardo
Neto, A. Patricia
Logodin, Enora
Pereira, Manuel F. R.
Sardo, Mariana
Rocha, Joao
Parpot, Pier
Fonseca, A. M.
Baltazar, Fátima
Neves, Isabel C.
dc.subject.por.fl_str_mv Science & Technology
topic Science & Technology
description Several silica microporous structures have been studied for their potential as drug delivery systems (DDS) over the last years. However, systematic studies comparing host structures with different topologies and particle sizes, and toxicity studies to human cancer cells, are scarce. In the present work, 3D crystalline structures, three different zeolites (large, medium and small pore size) and one titanosilicate (large pore size) were used as hosts for loading 5-fluorouracil (5-FU), an anticancer drug currently used to treat several malignant tumors. Here, we (i) compared the loading capacity and drug release profiles of the different hosts in simulated body fluid conditions, including host structure stability studies; (ii) established the kinetic parameters for the release of 5-FU and (iii) studied the effect of 5-FU encapsulation in the viability of human breast and colon cancer cells, with determination of the potentiation factor. The loading capacity and the release profile of the DDS were revealed to be dependent on the porous framework of the host structures. Decrease in pH to 2.0 (simulation of gastro-intestinal fluid), showed stability of the host structures, with minimal leaching of Al3+ and no Ti4+ for long periods of time (up to 72 h). All DDS drug release profiles fitted the Weibull model. These silica microporous structures were revealed to be non-toxic to the cancer cells, while all DDS endorsed the important 5-FU potentiation effect on cell viability.
publishDate 2017
dc.date.none.fl_str_mv 2017-01-01
2017-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/47909
url http://hdl.handle.net/1822/47909
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2046-2069
10.1039/c7ra01028a
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Royal Society of Chemistry
publisher.none.fl_str_mv Royal Society of Chemistry
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132826457604096